Comparative pharmacokinetics of salicylate in camels, sheep and goats

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

This study compared some pharmacokinetic parameters of DL-lysine-acetyl salicylate administered intravenously (i.v.) and intramuscularly (i.m.) at a dose of 20 mg/kg in camels, sheep and goats. The data was analyzed using a non-compartmental model. In camels, sheep and goats given the drug i.v., the t1/2 values were 43.1, 31.2 and 27.3; the clearance (CI) values were 203.7, 261.1, and 280.4 ml/h/kg, while the area under the curve (AUC) were 100.1, 106.9 and 110.5 mg.h/L, respectively. In camels, sheep and goats given the drug by the i.m. route the mean peak plasma concentration (Cmax) were 0.94, 1.44 and 1.74 mg/ml, and the time to reach Cmax (tmax) were 2.94, 2.57 and 2.43h, respectively. The t1/2 values were 48.9, 38.2 and 36.0 min; the clearance (CI) values were 261.3, 297.4 and 306.4 ml/h/kg, while the area under the curve (AUC) were 101.6, 117.3 and 123.7 mg.h/L, respectively. The drug bioavailability (F) in camels, sheep and goats were 71.3, 78.4 and 79.4% respectively. These findings suggest that the rate of absorption and elimination of the salicylate is slower in camels than in sheep and goats.

Original languageEnglish
Pages (from-to)125-128
Number of pages4
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Volume28
Issue number2
Publication statusPublished - Apr 2003

Fingerprint

Camelus
Salicylates
Goats
Sheep
Pharmacokinetics
Area Under Curve
Pharmaceutical Preparations
Biological Availability

Keywords

  • Camels
  • Goats
  • Pharmacokinetics
  • Salicylate
  • Sheep

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Comparative pharmacokinetics of salicylate in camels, sheep and goats. / Ali, B. H.

In: European Journal of Drug Metabolism and Pharmacokinetics, Vol. 28, No. 2, 04.2003, p. 125-128.

Research output: Contribution to journalArticle

@article{47954bd764a24e8a8608ca90e218195a,
title = "Comparative pharmacokinetics of salicylate in camels, sheep and goats",
abstract = "This study compared some pharmacokinetic parameters of DL-lysine-acetyl salicylate administered intravenously (i.v.) and intramuscularly (i.m.) at a dose of 20 mg/kg in camels, sheep and goats. The data was analyzed using a non-compartmental model. In camels, sheep and goats given the drug i.v., the t1/2 values were 43.1, 31.2 and 27.3; the clearance (CI) values were 203.7, 261.1, and 280.4 ml/h/kg, while the area under the curve (AUC) were 100.1, 106.9 and 110.5 mg.h/L, respectively. In camels, sheep and goats given the drug by the i.m. route the mean peak plasma concentration (Cmax) were 0.94, 1.44 and 1.74 mg/ml, and the time to reach Cmax (tmax) were 2.94, 2.57 and 2.43h, respectively. The t1/2 values were 48.9, 38.2 and 36.0 min; the clearance (CI) values were 261.3, 297.4 and 306.4 ml/h/kg, while the area under the curve (AUC) were 101.6, 117.3 and 123.7 mg.h/L, respectively. The drug bioavailability (F) in camels, sheep and goats were 71.3, 78.4 and 79.4{\%} respectively. These findings suggest that the rate of absorption and elimination of the salicylate is slower in camels than in sheep and goats.",
keywords = "Camels, Goats, Pharmacokinetics, Salicylate, Sheep",
author = "Ali, {B. H.}",
year = "2003",
month = "4",
language = "English",
volume = "28",
pages = "125--128",
journal = "European Journal of Drug Metabolism and Pharmacokinetics",
issn = "0378-7966",
publisher = "Springer Paris",
number = "2",

}

TY - JOUR

T1 - Comparative pharmacokinetics of salicylate in camels, sheep and goats

AU - Ali, B. H.

PY - 2003/4

Y1 - 2003/4

N2 - This study compared some pharmacokinetic parameters of DL-lysine-acetyl salicylate administered intravenously (i.v.) and intramuscularly (i.m.) at a dose of 20 mg/kg in camels, sheep and goats. The data was analyzed using a non-compartmental model. In camels, sheep and goats given the drug i.v., the t1/2 values were 43.1, 31.2 and 27.3; the clearance (CI) values were 203.7, 261.1, and 280.4 ml/h/kg, while the area under the curve (AUC) were 100.1, 106.9 and 110.5 mg.h/L, respectively. In camels, sheep and goats given the drug by the i.m. route the mean peak plasma concentration (Cmax) were 0.94, 1.44 and 1.74 mg/ml, and the time to reach Cmax (tmax) were 2.94, 2.57 and 2.43h, respectively. The t1/2 values were 48.9, 38.2 and 36.0 min; the clearance (CI) values were 261.3, 297.4 and 306.4 ml/h/kg, while the area under the curve (AUC) were 101.6, 117.3 and 123.7 mg.h/L, respectively. The drug bioavailability (F) in camels, sheep and goats were 71.3, 78.4 and 79.4% respectively. These findings suggest that the rate of absorption and elimination of the salicylate is slower in camels than in sheep and goats.

AB - This study compared some pharmacokinetic parameters of DL-lysine-acetyl salicylate administered intravenously (i.v.) and intramuscularly (i.m.) at a dose of 20 mg/kg in camels, sheep and goats. The data was analyzed using a non-compartmental model. In camels, sheep and goats given the drug i.v., the t1/2 values were 43.1, 31.2 and 27.3; the clearance (CI) values were 203.7, 261.1, and 280.4 ml/h/kg, while the area under the curve (AUC) were 100.1, 106.9 and 110.5 mg.h/L, respectively. In camels, sheep and goats given the drug by the i.m. route the mean peak plasma concentration (Cmax) were 0.94, 1.44 and 1.74 mg/ml, and the time to reach Cmax (tmax) were 2.94, 2.57 and 2.43h, respectively. The t1/2 values were 48.9, 38.2 and 36.0 min; the clearance (CI) values were 261.3, 297.4 and 306.4 ml/h/kg, while the area under the curve (AUC) were 101.6, 117.3 and 123.7 mg.h/L, respectively. The drug bioavailability (F) in camels, sheep and goats were 71.3, 78.4 and 79.4% respectively. These findings suggest that the rate of absorption and elimination of the salicylate is slower in camels than in sheep and goats.

KW - Camels

KW - Goats

KW - Pharmacokinetics

KW - Salicylate

KW - Sheep

UR - http://www.scopus.com/inward/record.url?scp=0037701032&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037701032&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 125

EP - 128

JO - European Journal of Drug Metabolism and Pharmacokinetics

JF - European Journal of Drug Metabolism and Pharmacokinetics

SN - 0378-7966

IS - 2

ER -